Skip to main navigation Skip to search Skip to main content

Response to Treatment with Intravenous Golimumab or Infliximab in Rheumatoid Arthritis Patients: PROMIS Results from the Real-World Observational Phase 4 AWARE Study

  • Clifton O. Bingham
  • , Shawn Black
  • , Natalie J. Shiff
  • , Stephen Xu
  • , Wayne Langholff
  • , Jeffrey R. Curtis

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Response to Treatment with Intravenous Golimumab or Infliximab in Rheumatoid Arthritis Patients: PROMIS Results from the Real-World Observational Phase 4 AWARE Study'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry